vidarabine has been researched along with valine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shiraki, K | 1 |
Dediulescu, DF; Dediulescu, L | 1 |
Cubitt, D; Dignan, F; Khot, A; Potter, M; Taylor, S; Treleaven, JG | 1 |
Chen, L; Ng, AP; Prince, HM; Seymour, JF; Slavin, M; Thursky, K; Worth, L | 1 |
Kimata, H | 1 |
Chinuki, Y; Dekio, I; Furumura, M; Morita, E | 1 |
Colby, KA; Liu, S; Pavan-Langston, D | 1 |
Aymerich, M; Campo, E; Colomer, D; López-Guerra, M; López-Otín, C; Matas-Céspedes, A; Montraveta, A; Pérez-Galán, P; Roldán, J; Rosich, L; Roué, G; Villamor, N; Xargay-Torrent, S | 1 |
2 review(s) available for vidarabine and valine
Article | Year |
---|---|
[Anti-herpetic chemotherapeutic drugs].
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpesviridae; Herpesviridae Infections; Humans; Idoxuridine; Protein Kinase Inhibitors; Thymidine Kinase; Valacyclovir; Valine; Vidarabine | 2003 |
[Antiherpetic therapy].
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine | 2005 |
6 other study(ies) available for vidarabine and valine
Article | Year |
---|---|
Another case of PORN (bilateral progressive outer retinal necrosis) after allogeneic stem cell transplantation.
Topics: Acyclovir; Administration, Oral; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cytarabine; DNA, Viral; Eye Infections, Viral; Granulocyte Colony-Stimulating Factor; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinitis; Stem Cell Transplantation; Transplantation, Homologous; Valacyclovir; Valine; Vidarabine | 2006 |
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Topics: Acyclovir; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cohort Studies; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Diphtheria Toxin; DNA, Viral; Doxorubicin; Female; Fever; Follow-Up Studies; Ganciclovir; Hematologic Neoplasms; Humans; Interleukin-2; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recombinant Fusion Proteins; Retrospective Studies; Rituximab; Transplantation, Autologous; Valacyclovir; Valine; Vidarabine; Vincristine; Viremia; Virus Activation | 2005 |
Kaposi's varicelliform eruption in a healthy adult.
Topics: Acyclovir; Administration, Cutaneous; Administration, Oral; Antiviral Agents; Humans; Immunoglobulin G; Immunoglobulin M; Kaposi Varicelliform Eruption; Male; Middle Aged; Ointments; Valacyclovir; Valine; Vidarabine | 2008 |
Recurrent Kaposi's varicelliform eruption successfully controlled by low-dose oral valaciclovir.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Dermatitis, Atopic; Humans; Immunoglobulin G; Kaposi Varicelliform Eruption; Male; Ointments; Recurrence; Treatment Outcome; Valacyclovir; Valine; Vidarabine; Young Adult | 2012 |
Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
Topics: 2-Aminopurine; Acyclovir; Administration, Topical; Adolescent; Age of Onset; Anterior Eye Segment; Antiviral Agents; Blepharitis; Child; Child, Preschool; Conjunctivitis, Viral; Eye Infections, Viral; Famciclovir; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Infant; Keratitis, Herpetic; Male; Ointments; Retrospective Studies; Trifluridine; Valacyclovir; Valine; Vidarabine | 2012 |
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
Topics: Aged; Amyloid Precursor Protein Secretases; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Receptor, Notch1; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine; Vidarabine | 2015 |